Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 43598-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a pharmaceutical label for Fosaprepitant for Injection, containing instructions for use, storage, and dosage information. It emphasizes the importance of proper reconstitution and dilution, as well as the need to refrigerate the vial after reconstitution. The medication should not be used with solutions containing divalent cations. The label also provides details about the inactive ingredients and the distributor of the product.*

FDA Label Image

Vial (Vial)

This is a description of the drug Fosaprepitant for Injection, which comes in vials containing 150 mg of the medication. The text also includes storage instructions (refrigerated at 2°C to 8°C), dosage information, and instructions for reconstitution and dilution before intravenous use. Additionally, it mentions the stability of the reconstituted solution for 24 hours at or below 25°C (77°F). The product is distributed by Dr. Reddy's Laboratories Inc. in the USA.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.